Open access · OA
via OpenAlex
Hematopoietic Stem Cells with High Proliferative Potential
Dane R. Boggs, Sallie S. Boggs, Debra Saxe, Lora A. Gress, Don R. Canfield
Journal of Clinical Investigation · 1982 · ▲ 144 citations
Abstract
THIS STUDY WAS DESIGNED TO APPROACH TWO PRIMARY QUESTIONS CONCERNING HEMATOPOIETIC STEM CELLS (HSC) IN MICE: what is the concentration of HSC with extensive proliferative potential in marrow, and how long can an HSC continue to function in an intact animal? The assay system was the W/W(v) mouse, a mouse with an inherited HSC defect, reflected in a reduction in all myeloid tissue and most particularly in a macrocytic anemia.A single chromosomally marked HSC will reconstitute the defective hematopoietic system of the W/W(v). The concentration of HSC in normal littermate (+/+) marrow was assayed by limiting dilution calculation using cure of W/W(v) as an end point (correction of anemia and erythrocytes' macrocytosis) and found to be approximately 10/10(5). This is significantly less than spleen colony forming cell (CFU-S) concentration: approximately 220/10(5) in +/+ and ranging from 50 to 270/10(5) in various other studies. Blood values were studied at selected intervals for as long as 26 mo. Of 24 initially cured mice, which were observed for at least 2 yr, 75% remained cured. However, of all cured mice, 17 lost the cure, returning to a macrocytic anemic state. Cured mice had normal numbers of nucleated and granulocytic cells per humerus and a normal concentration of CFU-S. However, cure of secondary W/W(v) recipients by this marrow was inefficient compared with the original +/+ marrow. These studies suggest the CFU-S assay over-estimates extensively proliferating HSC or perhaps does not assay such a cell. A single such HSC can not only cure a W/W(v), but can sustain the cure for 2 yr or more, despite a relative deficit of cells capable of curing other W/W(v). However, the duration of sustained cure may be finite.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1172/jci110611
- Canonical
- link ↗
- Fetched
- 2026-06-11 MST
Cite this
APA
Boggs, D.R., Boggs, S.S., Saxe, D., Gress, L.A., & Canfield, D.R. (1982). Hematopoietic Stem Cells with High Proliferative Potential. <em>Journal of Clinical Investigation</em>. https://doi.org/10.1172/jci110611
Vancouver
Boggs DR, Boggs SS, Saxe D, Gress LA, Canfield DR. Hematopoietic Stem Cells with High Proliferative Potential. Journal of Clinical Investigation. 1982. doi:10.1172/jci110611.
BibTeX
@article{dane1982Hemato,
title = {Hematopoietic Stem Cells with High Proliferative Potential},
author = {Dane R. Boggs and Sallie S. Boggs and Debra Saxe and Lora A. Gress and Don R. Canfield},
journal = {Journal of Clinical Investigation},
year = {1982},
doi = {10.1172/jci110611},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Leukemia 2007
Open access · OA
Bone marrow mesenchymal stem cells are abnormal in multiple myeloma
eLife 2014
Open access · CC-BY
The neural crest is a source of mesenchymal stem cells with specialized hematopoietic stem cell niche function
BMC Genomics 2010
Open access · CC-BY
Age-related molecular genetic changes of murine bone marrow mesenchymal stem cells
Arthritis Research & Therapy 2007
Open access · OA
Mesenchymal stromal cells. Biology of adult mesenchymal stem cells: regulation of niche, self-renewal and differentiation.
The Lancet Respiratory Medicine 2014
Preprint · OA
Mesenchymal stem cells: mechanisms of potential therapeutic benefit in ARDS and sepsis
Experimental Gerontology 2005
Citation only